🇺🇸 FDA
Patent

US 6583143

CRF receptor antagonists and methods relating thereto

expired A61KA61K31/53A61P

Quick answer

US patent 6583143 (CRF receptor antagonists and methods relating thereto) held by Neurocrine Biosciences, Inc. expires Mon Jun 19 2023 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Neurocrine Biosciences, Inc.
Grant date
Tue Jun 24 2003 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 19 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K31/53, A61P, A61P1/04, A61P1/14